Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/nUbghMrCCBALyljYKf

December 16, 2008News for medical technology professionals

  Top Story 
 
Leveraging the Benefits of eMDR: A Guide to Taking Advantage of eMDR (electronic medical device reporting) to Improve your Operations – Learn how eMDR works, what the FDA says about it, and benefits of adopting the technology through developing an effective strategy now. Request your copy here
  Business & Market Trends 
  • Neuromonics wins Pentagon grant to test tinnitus device
    Neuromonics has secured a $1 million grant from the Department of Defense to start a study aimed at testing the efficacy of its device for tinnitus among members of the military with the condition, which is also known as "ringing of the ears." The product, which is similar to an MP3 player, lets patients listen to music to help the brain screen out tinnitus. The Express-Times (Easton-Bethlehem, Pa.) (12/16) LinkedInFacebookTwitterEmail this Story
  • AtriCure shareholders file suit over financial statements
    Investors have filed a class-action case against AtriCure in federal court in Cincinnati, alleging that the company falsified financial statements submitted to the Securities and Exchange Commission. The lawsuit comes after the Justice Department began examining whether the firm used unlawful methods to promote its surgical-ablation devices, which have not received FDA approval. AtriCure said it will "vigorously defend" itself against the suit. The Western Star (Lebanon, Ohio) (12/15) LinkedInFacebookTwitterEmail this Story
  • SEC filing: TransMedics drops plans to go public
    TransMedics has called off a plan for an initial public offering because of unfavorable market conditions, according to a filing with the Securities and Exchange Commission. The startup firm hoped to secure $86.3 million from the IPO to develop and commercialize its Organ Care System, a product designed to maintain the freshness of organs intended for transplantation. Mass High Tech (Boston) (12/15) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  • Study: Colonoscopy less accurate than previously thought
    A Canadian study found that colonoscopies failed to spot almost every cancer in the right side of the colon and missed approximately one-third of tumors in the left side. Screening experts suggest that patients should continue to undergo the procedure because it remains an effective preventive measure, but they should look for more experienced colonoscopists. NYTimes.com (12/15) LinkedInFacebookTwitterEmail this Story
  • Study links self-referrals to increase in nuclear MPI use
    A U.S. study found that the use of nuclear myocardial perfusion imaging among cardiologists increased by 159% between 1998 and 2006. The finding suggests that the surge is likely driven by self-referrals because "there is no evidence for increase in incidence of coronary artery disease," said Dr. David Levin, who presented the study. Such practice should be avoided to ensure that imaging costs are not unnecessarily inflated, Levin said. AuntMinnie.com (free registration) (12/15) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
The Buzz(CORPORATE ANNOUNCEMENTS)

Combined Expertise – Superior Protection
When a medical technology company employee died from what appeared to be a non-life threatening work-related injury, management learned the value of partnering with an insurance company capable of providing superior protection and expertise. Click here to learn why your insurance partner makes a difference.
www.medmarc.com                     www.thehartford.com

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits.  

  Government & Regulatory 
  • FDA chief to step down on Inauguration Day
    FDA Commissioner Dr. Andrew von Eschenbach notified agency officials that he intends to leave his post Jan. 20. In the internal memo, von Eschenbach said he will cooperate with President-elect Barack Obama's transition group "to ensure a seamless change in political leadership at the agency." The Wall Street Journal (12/15) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Massachusetts Code of Medical Device Manufacturer Conduct
      
    Massachusetts is preparing regulations to implement a first-of-its-kind drug and medical-device marketing law requiring firms to abide by a state-developed code of conduct and to report payments to health care providers. Every device firm needs to understand the implications of this law, which will significantly affect activities in Massachusetts and may be copied in other states and at the federal level. Join us Jan. 7, 2009, from 2 to 3:30 p.m. EST as experts intimately familiar with the Massachusetts law and evolving thoughts on its implementation and company best practices share their knowledge and experience. Learn what will and will not be permitted under the law, the implementation timetable and the status of marketing restrictions in other states and at the federal level. Register now. Medical Technology Learning Institute -- Education Beyond a Degree LinkedInFacebookTwitterEmail this Story
  • Investigational Device Exemption Submission workshop
     
    MTLI offers this one-day interactive workshop on Feb. 25, 2009, in Las Vegas, to lead attendees through the regulatory and practical guidelines governing when an IDE is required, how to compile an effective IDE application, the rules governing clinical studies and human subject protection, Institutional Review Boards, types of pre-IDE meetings and communications, early/expanded access, foreign studies and export, and reimbursement for investigational devices. Register now. Medical Technology Learning Institute -- Education Beyond a Degree LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed  |  Join  |  Courses  |  Events  |  Newsroom

 
Position TitleCompany NameLocation
Senior Regulatory ManagerBIOTRONIK, Inc.Portland, Oregon
Director of MarketingHeart Rhythm SocietyWashington DC
Manager, Practice Management and ReimbursementHeart Rhythm SocietyWashington DC
Associate Director QA/RAATEX Technologies, Inc.Pinebluff, North Carolina
Click here to view more job listings.

  SmartQuote 
If I make a fool of myself, who cares? I'm not frightened by anyone's perception of me."
--Angelina Jolie,
actress


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Ashley McMaster
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information